Journal of Neuroimmunology

Article	Citations
Editorial Board	104
Subunit-specific autoantibodies in autoimmune autonomic ganglionopathy	84
Cytokine profile and brain biopsy in a case of childhood-onset central nervous system vasculitis in Noonan syndrome-like disorder due to a novel CBL variant	81
Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases	81
MicroRNAs are dysregulated in peripheral blood mononuclear cells in multiple sclerosis and correlate with T cell mediators	71
Stiff person syndrome spectrum disorders; more than meets the eye	48
Priming of microglia by type II interferon is lasting and resistant to modulation by interleukin-10 in situ	47
Serum from Myalgic encephalomyelitis/chronic fatigue syndrome patients causes loss of coherence in cellular circadian rhythms	41
Lymphomas mimicking neuroinflammatory diseases – A diagnostic conundrum worth revisiting	40
Microglial-mediated immune mechanisms in autoimmune uveitis: Elucidating pathogenic pathways and targeted therapeutics	37
An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote	31
Genome-wide identification of murine interferon genes in microglial-mediated neuroinflammation in Alzheimer's disease	31
Nicotine is an Immunosuppressant: Implications for Women's Health and Disease	28
The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation	27
Ursolic acid enhances social behavior and modulates Th1, Th17, and T regulatory cell-related transcription factor signaling in the BTBR T+ Itpr3tf/J mouse model of autism	25
A complex and severe encephalitis associated with four co-existing neuronal cell-surface autoantibodies	24
Letter to the Editor Regarding “Spinocerebellar ataxia masquerading as multiple sclerosis, a case report”	23
Mononuclear phagocytes in blood and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis: Untreated and treated with anti-CD20 therapy	23
Neuroinflammation and schizophrenia: The role of Toxoplasma gondii infection and astrocytic dysfunction	22
Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial	22
A rare cause of visual impairment in patients with multiple sclerosis: Uveitis	22
Associations between serum levels of alpha-calcitonin gene-related peptide and clinical features of neuromyelitis optica spectrum disorders	21
Free light chains as a reliable biomarker of intrathecal synthesis in the diagnosis of CNS inflammatory diseases	20
Occult cartilaginous choristoma in a child with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis	20
HMGB1/TLR4 axis promotes pyroptosis after ICH by activating the NLRP3 inflammasome	19

Treatment with sofosbuvir attenuates the adverse neurodevelopmental consequences of Zika virus infection in infant rhesus macaques	19
Microscopic Polyangiitis With a Twist: A Rare Case of CRAO and Brainstem Infarction	19
Low vitamin D status is associated with inflammatory response in older patients with cerebral small vessel disease	18
Neuromyelitis optica spectrum disorder mimicking stroke: A case report and literature review	18
Editorial Board	18
Unilateral cortical autoimmune encephalitis: A case series and comparison to late-onset Rasmussen's encephalitis	18
Sjogren's syndrome meets Meige's syndrome	18
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4	17
Sexual dimorphism of hypothalamic serotonin release during systemic inflammation: Role of endothelin-1	17
Regulatory T cells in children with attention deficit hyperactivity disorder: A case-control study	17
Prognostic significance of PD-L1 and CD45RO+ cells in glioblastoma: The modulating role of MMR status	17
Eculizumab treatment for myasthenia gravis subgroups: 2021 update	17
Editorial Board	16
Expression of cerebellar degeneration-related proteins CDR2 and CDR2L in human and rat brain tissue	16
Clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children: A case series of 16 patients	16
Heightened effector immune cell infiltration of the hippocampus concurrently with brain ventricular volume expansion in aged APP/PS1 mice	16
In memoriam: Jennifer L. Stark, PhD	15
Anti-N-methyl-d-aspartate receptor encephalitis preceded by meningitis lasting up to 60 days	15
Adult-onset neurodegeneration in XMEN disease	15
Editorial Board	15
Atypical clinical and novel radiological findings in Susac syndrome: Experience from a large monocentric cohort	15
HLA-G*14 bp indel variant in autism spectrum disorder in a population from southern Brazil	14
Serum HGF and APN2 are associated with disability worsening in SPMS	14
A 7-year-old with new-onset seizures, behavior disturbance, and encephalitis	14
Using interleukin-18, Eotaxin-1, and Eotaxin-3 to identify brain injury in neonates with congenital heart disease	14
Retinal pathology in spontaneous opticospinal experimental autoimmune encephalitis mice	14
Characterization of Japanese multiple sclerosis patients with progression independent of relapse activity: A 2-year multicenter cohort study	14
Characteristics and prognosis of PCA-1 (anti-Yo) autoimmunity and the utility of the Brief Ataxia Rating Scale in a seropositive cerebellar ataxia cohort	14
Ido1 or Ido2 deficiency in myeloid-derived cells attenuates TMEV-induced ictogenesis	14
d-serine prevents cognitive impairment in a mouse model of NMDAR encephalitis	13
"Lipopolysaccharide-induced animal models for neuroinflammation – An overview."	13
Distinguishing CNS neurosarcoidosis from multiple sclerosis and an approach to “overlap” cases	13
Association of interleukins 17A and 22 levels and their common genetic polymorphisms in Guillain Barré syndrome	13
Ginkgo biloba extract (EGb-761) confers neuroprotection against ischemic stroke by augmenting autophagic/lysosomal signaling pathway	13
Clinico-pathological correlation in unilateral cortical encephalitis treated with tocilizumab after first-line treatment failure	13
Neuro-ophthalmological manifestations of sarcoidosis	13
Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis	12
A functional role for alpha-synuclein in neuroimmune responses	12
Circulating levels of inflammatory biomarkers in Huntington's disease: A systematic review and meta-analysis	12
Effects of androgen modifying therapies on disease activity in older men with multiple sclerosis	12
Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis	12
Exosome-transmitted ANGPTL1 suppresses angiogenesis in glioblastoma by inhibiting the VEGFA/VEGFR2/Akt/eNOS pathway	12
Autoimmune encephalitis misdiagnosis and mimics	12
Editorial Board	12
The pathophysiology of major depressive disorder through the lens of systems biology: Network analysis of the psycho-immune-neuroendocrine physiome	12
Elevated serum levels of IL-10 family and IL-12 family cytokines in myasthenia gravis	12
Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosis	12
Therapeutic potential of Baicalin against experimental obsessive compulsive disorder: Evidence from CSF, blood plasma, and brain analysis	12
Causal relationships between monocyte chemoattractant protein-1 levels and neuropsychiatric disorders: Evidence from large-scale genetic data	12
Neoehrlichiosis in patients with multiple sclerosis in Halmstad, Sweden: A case series	11

Chronic g-CSF increases the neutrophil-lymphocyte ratio and decreases plasma corticosterone concentrations in Peromyscus maniculatus without impacting compulsive-like stereotypy	11
Editorial Board	11
Identification of the core genes KLRB1 and RETN as potential shared diagnostic markers for major depressive disorder and systemic lupus erythematosus through bioinformatics and machine learning method	11
Early life stress aggravates disease pathogenesis in mice with experimental autoimmune encephalomyelitis: Support for a two-hit hypothesis of multiple sclerosis etiology	11
Activated microglia by 18F-DPA714 PET in a case of anti-LGI1 autoimmune encephalitis	11
Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations	11
Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis	11
Minocycline inhibits microglial activation in the CA1 hippocampal region and prevents long-term cognitive sequel after experimental cerebral malaria	11
Age and sex-dependent gut alterations in mice induced by neonatal immune activation with lipopolysaccharide	11
Macrophage-derived exosomes exacerbate postoperative cognitive dysfunction in mice through inflammation	10
Glial changes in the dentate gyrus of neuronal-specific PTEN knockout mice correlate with changes in cell proliferation	10
Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosis	10
Oral D-mannose treatment suppresses experimental autoimmune encephalomyelitis via induction of regulatory T cells	10
Impact of blood-brain barrier disruption on clinical features and treatment response in patients with newly diagnosed autoimmune encephalitis	10
3D imaging and pathological analysis of microglia in LPS-treated mice with light-sheet fluorescence microscopy	10
The role of TREM1 in regulating microglial polarization in sevoflurane-induced perioperative neurocognitive disorders	10
Serum levels of lipocalin-2 are elevated at early times in African American relapsing remitting multiple sclerosis patients	10
SPI1 affects Aβ1–42-induced microglia-mediated neuroinflammation by transcriptionally regulating FOSL2 expression	10
Genetic deletion of c-Jun amino-terminal kinase 3 (JNK3) modestly increases disease severity in a mouse model of multiple sclerosis	10
Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility study	10
Are corneal nerve and dendritic cell parameters assessed via corneal confocal microscopy good markers for multiple sclerosis? – A systematic review and meta-analysis	10
Immunological heterogeneity in Ménière's disease: CD4+ T cell subset profiling reveals three distinct Immunophenotypes	10
Calcitonin gene-related peptide upregulates IL-17A and IL-22 in γδ-T cells through the paracrine effect of langerhans cells on LC/γδ-T co-culture model	9
The role of the immune system in Parkinson's disease pathogenesis: A focus on Th17 cells - A systematic review and meta-analysis	9
Neuromodulator hydrogen sulfide attenuates sickness behavior induced by lipopolysaccharide	9
Anti-Lactosylceramide antibody positive combined central peripheral demyelination emerging from long-standing juvenile-onset chronic inflammatory polyradiculoneuropathy; a report of two cases	9
Bioinformatics exploration of SPHKAP's role in IDH-mutant glioma involving energy metabolism, prognosis, and immune modulation	9
Maresin1 improves postoperative delirium-like behavior in mice with tibial fractures by inhibiting the TLR4/MyD88/NF-kB pathway	9
An enjoyable career in science	9
Effects of a high saturated fatty acid diet on the intestinal microbiota modification and associated impacts on Parkinson's disease development	9
Editorial Board	9
Analysis of risk factors for a poor functional prognosis and relapse in patients with autoimmune encephalitis	9
The medulla oblongata shows a sex-specific inflammatory response to systemic neonatal lipopolysaccharide	9
Human dendritic cell subsets in the glioblastoma-associated microenvironment	9
Editorial Board	9
Apathy in autoimmune GFAP Astrocytopathy: A case series and literature review	9
Editorial Board	9
Peripheral and central inflammation in depression: How large is the gap and can we bridge it with PET neuroimaging and neural-derived extracellular vesicles?	9
Iatrogenic NORSE: Immune checkpoint inhibitor-related anti-GFAP autoimmune astrocytopathy	9
Comparison of the clinical syndromes of anti-GABAa versus anti-GABAb associated autoimmune encephalitis: A systematic review	9
Relationship of selective complement markers with schizophrenia	9
Calcitriol modulate post-ischemic TLR signaling pathway in ischemic stroke patients	9
Neuro-Sjögren: A clinical-radiological paradox affecting the central nervous system	9
Bridging the triad: A comprehensive review of Susac's syndrome	9
Geraniol (GER) attenuated chronic sleep restriction (CSR)-induced neuroinflammation in adolescent mice	9
Adenylate kinase 5 (AK5) autoimmune encephalitis: Clinical presentations and outcomes in three new patients	8
The therapeutic effect of ofatumumab in autoimmune encephalitis: A case series	8
Elevated serum levels of C-terminal agrin fragment in acetylcholine receptor antibody-positive myasthenia gravis	8
Disordered gut microbiota and changes in short-chain fatty acids and inflammatory processes in stress-vulnerable mice	8
Wash-out duration and lymphocyte count in switching from fingolimod to ofatumumab: A case report and literature review	8
Cadmium exposure exacerbates immunological abnormalities in a BTBR T+ Itpr3tf/J autistic mouse model by upregulating inflammatory mediators in CD45R-expressing cells	8
Cerebral amyloid angiopathy-related inflammation superimposed on alpha-synucleinopathies: a case report and literature review	8
Plasma TNF-α and phosphorylated α-syn are associated with fatigue in patients with Parkinson's disease	8
Novel biomarkers and interferon signature in secondary progressive multiple sclerosis	8
Granagard administration prolongs the survival of human mesenchymal stem cells transplanted into a mouse model of multiple sclerosis	8
Normocomplementemic urticarial vasculitis in a patient with multiple sclerosis on glatiramer acetate	8
Discordance of reported multiple sclerosis clinical course amongst patients and providers	8
Syringic acid suppresses inflammation by upregulation of SOCS3	8
Peripheral neuropathy in sarcoidosis	8
Bergapten inhibiting NLRP3 inflammasome activation and pyroptosis to alleviate neuropathic pain in a rat mode of chronic constriction injury	8
Local immunotherapy of glioblastoma: A comprehensive review of the concept	8
Myeloid cell heterogeneity in the tumor microenvironment and therapeutic implications for childhood central nervous system (CNS) tumors	8
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Practical recommendations for diagnosis and management	7
When gut and nerves collide: A case of Neuromyelitis Optica Spectrum disorder after golimumab for ulcerative colitis	7
Neuronal inflammation-associated biomarkers in cerebrospinal fluid of patients with acute and chronic inflammatory demyelinating polyneuropathies	7
Gut dysbiosis influences the pathophysiology of multiple sclerosis: A case-control study from North India	7
The PTEN-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma	7
Kidney injury: An overlooked manifestation in autoimmune encephalitis	7
Exploring the causal role of immune cells in vascular dementia: A bidirectional mendelian randomization study	7
Structural and functional biomarkers of visual dysfunction in MOG antibody-positive optic neuritis: a scoping review	7
The real-world experience of biologics for neuromyelitis optica spectrum disorders as first-line and switched therapy	7
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center	7
Guhong injection attenuates brain injury and promotes neuroprotection after acute ischemic stroke	7
A three-compartment apparatus alters the brain concentration of cytokines and neurotrophic factors in cocaine-induced CPP in mice	7
Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?	7
miR-92a-3p regulates neuropathic pain and neuroinflammation by regulating the expression of WNT5A	7
Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS)	7
Effect of the sEH inhibitor AUDA on arachidonic acid metabolism and NF-κB signaling of rats with postpartum depression-like behavior	7
Aggressive MOGAD with bilateral corticospinal tract lesions following infection with Jamestown Canyon virus	7
Viral co-infection, autoimmunity, and CSF HIV antibody profiles in HIV central nervous system escape	7

Fibrinolysis associated proteins and lipopolysaccharide bioactivity in plasma and cerebrospinal fluid in multiple sclerosis	7
Presumptive isolated neurosarcoidosis involving eloquent structures: An argument for empirical TNF-α inhibition	7
Exploring the role of the IL-12/IFN-γ immune axis in subacute sclerosing panencephalitis	7
Self-delivering mRNA inhibitors of MK2 improve outcomes after spinal cord injury	7
Caveolin-1 mediates blood-brain barrier permeability, neuroinflammation, and cognitive impairment in SARS-CoV-2 infection	7
Interleukin-17 is involved in neuropathic pain and spinal synapse plasticity on mice	7
Prolonged STAT1 activation in neurons drives a pathological transcriptional response	7
Autoantigen and IL-2 activated CD4+CD25+T regulatory cells are induced to express CD8 and are autoantigen specific in inhibiting experimental autoimmune encephalomyelitis	7
Inherited chromosomally-integrated human herpes virus 6 confounding test results in a patient with myelitis and optic neuritis – A case report	7
Editorial Board	7
Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis	7
Ovariectomy increases paclitaxel-induced mechanical hypersensitivity and reduces anti-inflammatory CD4+ T cells in the dorsal root ganglion of female mice	7
Predictors from systemic and neuro-inflammation in amyotrophic lateral sclerosis: A monocentric experience	7
Comparison of prednisolone monotherapy vs. tacrolimus combination in NMOSD: Efficacy, safety, and optimal therapeutic timing	7
Editorial Update	7
MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis	7
Antibiotic treatment during pregnancy and lactation in dams exacerbates clinical symptoms and inflammatory responses in offspring with experimental autoimmune encephalomyelitis	6
Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan	6
Cerebellar ataxia and depression associated with anti-RhoGTPase-activating protein 26 antibody: A case report	6
Efficacy and tolerability of metformin as an adjuvant therapy in patients with relapse-remitting multiple sclerosis receiving interferon Beta 1a: A randomized pilot trial	6
Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection	6
Immunological predictors for the outcome in patients with antibody-mediated autoimmune encephalitis	6
IT-DEX and B cell depletion in a child with anti-GAD 65 autoimmune encephalitis presenting as NORSE: A case report	6
3D in vitro modelling of human patient microglia: A focus on clinical translation and drug development in neurodegenerative diseases	6
Characterizing the relationship between FLAIR hyper-rim lesions and paramagnetic rim lesions in multiple sclerosis	6
Characterization of cerebral small vessel disease by neutrophil and platelet activation markers using artificial intelligence	6
miR-485 regulates Th17 generation and pathogenesis in experimental autoimmune encephalomyelitis through targeting STAT3	6
Exogenous IL-33 mitigates inflammatory responses by suppressing the NF-Κb signaling pathway, promoting blood-spinal cord barrier repair and neural functional recovery	6
Immunostimulatory and immunomodulatory effects of duloxetine and venlafaxine on p38 MAPK and PI3K pathways	6
Platelets bridging the gap between gut dysbiosis and neuroinflammation in stress-linked disorders: A narrative review	6
Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab	6
Alterations in brainstem respiratory centers following peripheral inflammation: A systematic review	6
Double hit – A case in point for dual seropositivity to AQP4 and MOG antibodies	6
The effect of immunosuppression or thymectomy on the response to tetanus revaccination in myasthenia gravis	6
Corrigendum to “MP4- and MOG:35–55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum” [J Neuroimmunol 189(1–2) (2007) 31–40]	6
Editorial Board	6
The dilemma of demyelination: A case of Schilder's disease with insights from literature	6
Fluorescence-detection size-exclusion chromatography specifically detects autoantibodies targeting the ganglionic acetylcholine receptor in patients with autoimmune autonomic ganglionopathy	6
Management of neurosarcoidosis	6
RIPK3-MLKL dependent necroptosis mediates depressive-like behavior by facilitating neuroinflammation	6
Tumefactive demyelination as the first presentation of MOG ab-associated disease	6
Hypertrophic pachymeningitis with co-occurrence of anti-neutrophil cytoplasmic antibodies and immunoglobulin G4 seropositivity: Case report and literature review	6
Weight-drop model as a valuable tool to study potential neurobiological processes underlying behavioral and cognitive changes secondary to mild traumatic brain injury	6
The case report of AQP4 and MOG IgG double positive NMOSD treated with subcutaneous Ofatumumab	6
Association of thyroid autoimmune status with Alzheimer’s disease biomarkers in euthyroid subjects	6
Targeting extracellular matrix components to attenuate microglia neuroinflammation: A study of fibulin-2 and CSPGs in a model of multiple sclerosis	5
The status of knowledge on migraines: The role of microglia	5
Immunotherapy challenges and potential role of unclassified antibodies in complex autoimmune encephalitis	5
Immune dysfunction in the cerebellum of mice lacking the autism candidate gene Engrailed 2	5
Pediatric anti-CaVα2δ autoimmune encephalitis: A case report and literature review	5
Comment on “SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fiber neuropathy by J. Finsterer	5
Offspring behavioral outcomes following maternal allergic asthma in the IL-4-deficient mouse	5
Atractylodin ameliorates lipopolysaccharide-induced depressive-like behaviors in mice through reducing neuroinflammation and neuronal damage	5
Epileptic seizures in patients with anti-IgLON5 disease	5
Corrigendum to “Germinal center B cells are dispensable in prion transport and neuroinvasion”. [2007 Dec;192(1–2):113–23. doi: 10.1016/j.jneuroim.2007.09.022. Epub 2007 Oct 26. PMID: 17964667]	5
Neurotropic murine coronavirus mediated demyelination: Factors dampening pathogenesis	5
Susac syndrome with the typical clinical triad: A case report and literature review	5
Peripheral oedema as an adverse effect of treatment of secondary progressive multiple sclerosis with siponimod: A case series	5
Anti-contactin-associated protein 1 antibody-positive nodopathy presenting with central nervous system symptoms	5
Pure spinal multiple sclerosis: A case series of a possible new entity	5
Chronic sleep loss alters the inflammatory response and BDNF expression in C57BL/6J mice	5
Microglia mediated neuroinflammation in neurodegenerative diseases: A review on the cell signaling pathways involved in microglial activation	5
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab	5
LRP4 antibody testing in myasthenia gravis	5
Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab	5
Corrigendum to “Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis” [Journal of neuroimmunology vol.	5
The microglial endocannabinoid system is similarly regulated by lipopolysaccharide and interferon gamma	5
ITPR1 autoantibody-associated autoimmunity as a cause of newly emerging cognitive decline mimicking Alzheimer's disease: Case report and brief review of the literature	5
Alemtuzumab treatment exemplifies discordant immune effects of blood and cerebrospinal fluid in multiple sclerosis	5
Bladder dysfunction in experimental autoimmune encephalomyelitis reflects clinical severity: A pilot study	5
Clinical outcome and peripheral CD4+ T profile in impending myasthenic crisis: A prospective cohort study	5
Anti-Tr/DNER antibody-associated rapidly progressive cerebellar degeneration in anaplastic large cell lymphoma: A case report with literature review	5
A systematic review of cases of CNS demyelination following COVID-19 vaccination	5
Editorial Board	5
Editorial Board	5
As time goes by: Treatment challenges in elderly people with multiple sclerosis	4
Celia Fildes Brosnan (Jan. 5, 1938 – Feb. 10, 2025) Neuroimmunologist and Friend Extraordinaire	4
Cholesterol dysregulation in peripheral blood mononuclear cells of Alzheimer's disease	4
Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis	4
Fingolimod attenuates gait deficits in mice subjected to experimental autoimmune encephalomyelitis	4
Anti-CD20 treatment and neutrophil function in central nervous system demyelinating diseases	4
Association of ADHD symptoms, pain, and tics with anti-thalamus antibodies in cerebrospinal fluid	4
Nanopore sequencing identifies differentially methylated genes in the central nervous system in experimental autoimmune encephalomyelitis	4
Advanced quantitative MRI reveals a unique pattern of metabolic alterations and iron-pathology linked to glial activation in Baló's concentric sclerosis	4
Endocrine disrupting chemicals in early MS disease activity	4
Exploring lipophilic compounds that induce BDNF secretion in astrocytes beyond the BBB using a new multi-cultured human in vitro BBB model	4
Electroconvulsive therapy for catatonia in anti-NMDA receptor encephalitis: A case series	4
Prolonged and intense neuroinflammation after severe traumatic brain injury assessed by cerebral microdialysis with 300 kDa membranes	4
AMPAR autoimmunity: Neurological and oncological accompaniments and co-existing neural autoantibodies	4
Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis	4
Genetically reduced MTHFR activity confers protection against multiple sclerosis	4
HMGB1 plays an important role in pyroptosis induced blood brain barrier breakdown in diabetes-associated cognitive decline	4
Prolonged corticosteroid therapy and steroid-sparing maintenance immunotherapy lower relapse risk in pediatric and adult MOGAD	4
Neuroimmunology in globoid cell leukodystrophy: A comprehensive review including treatments, models, and neuroimmune mechanisms underlying neuropathology	4
Immune dysregulation in chronic inflammatory demyelinating polyneuropathy	4